Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 91, Issue 5, 2015, Pages 925-933

  Vainshtein, Jeffrey M ^a   Moon, Dominic H ^b   Feng, Felix Y ^a   Chepeha, Douglas B ^b   Eisbruch, Avraham ^a   Stenmark, Matthew H ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; PATIENT MONITORING; QUALITY CONTROL; SURVEYS;

HEALTH-RELATED QUALITY OF LIVES; HUMAN PAPILLOMAVIRUS; INTENSITY MODULATED RADIATION THERAPY; LONG-TERM FOLLOW-UP; METHODS AND MATERIALS; OROPHARYNGEAL CANCER; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; UNIVERSITY OF WASHINGTON;

RADIOTHERAPY;

CARBOPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CHEMO INTENSITY MODULATED RADIATION THERAPY; CHEMORADIOTHERAPY; FEMALE; FOLLOW UP; HEAD AND NECK QUALITY OF LIFE QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; SWALLOWING; UNIVERSITY OF WASHINGTON QUALITY OF LIFE QUESTIONNAIRE; VERY ELDERLY; WART VIRUS; XEROSTOMIA QUESTIONNAIRE; COMPLICATION; CONSERVATIVE TREATMENT; DEGLUTITION DISORDERS; ESOPHAGUS; HEALTH STATUS; INTENSITY MODULATED RADIATION THERAPY; LARYNX; LONGITUDINAL STUDY; MIDDLE AGED; MORTALITY; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PHARYNGEAL MUSCLE; PROCEDURES; RADIATION RESPONSE; SALIVARY GLAND; SURVIVOR; VIROLOGY; XEROSTOMIA;

ADULT; AGED; CHEMORADIOTHERAPY; DEGLUTITION; DEGLUTITION DISORDERS; ESOPHAGUS; FEMALE; HEALTH STATUS; HUMANS; LARYNX; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; ORGAN SPARING TREATMENTS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PHARYNGEAL MUSCLES; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIOTHERAPY, INTENSITY-MODULATED; SALIVARY GLANDS; SURVEYS AND QUESTIONNAIRES; SURVIVORS; XEROSTOMIA;

EID: 84925339841     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.12.045     Document Type: Article

References (36)

1. J.E. Terrell, D.L. Ronis, and K.E. Fowler Clinical predictors of quality of life in patients with head and neck cancer Arch Otolaryngol Head Neck Surg 130 2004 401 408
2. K.U. Hunter, M. Schipper, and F.Y. Feng Toxicities affecting quality of life after chemo-IMRT of oropharyngeal cancer: Prospective study of patient-reported, observer-rated, and objective outcomes Int J Radiat Oncol Biol Phys 85 2013 935 940
3. A. Eisbruch, M. Schwartz, and C. Rasch Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 60 2004 1428 1439
4. A. Eisbruch, H.M. Kim, and J.E. Terrell Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer Int J Radiat Oncol Biol Phys 50 2001 695 704
5. F.Y. Feng, H.M. Kim, and T.H. Lyden Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: Early dose-effect relationships for the swallowing structures Int J Radiat Oncol Biol Phys 68 2007 1289 1298
6. S. Jabbari, H.M. Kim, and M. Feng Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: Initial report Int J Radiat Oncol Biol Phys 63 2005 725 731
7. C.M. Nutting, J.P. Morden, and K.J. Harrington Parotid- sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial Lancet Oncol 12 2011 127 136
8. F.Y. Feng, H.M. Kim, and T.H. Lyden Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: Clinical and functional results J Clin Oncol 28 2010 2732 2738
9. N. Payakachat, S. Ounpraseuth, and J.Y. Suen Late complications and long-term quality of life for survivors (>5 years) with history of head and neck cancer Head Neck 35 2013 819 825
10. K.A. Hutcheson, J.S. Lewin, and D.A. Barringer Late dysphagia after radiotherapy-based treatment of head and neck cancer Cancer 118 2012 5793 5799
11. K.U. Hunter, L.L. Fernandes, and K.A. Vineberg Parotid glands dose-effect relationships based on their actually delivered doses: Implications for adaptive replanning in radiation therapy of head-and-neck cancer Int J Radiat Oncol Biol Phys 87 2013 676 682
12. J.M. Vainshtein, M.E. Spector, and J.B. McHugh Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer Oral Oncol 50 2014 513 519
13. J.E. Terrell, K.A. Nanavati, and R.M. Esclamado Head and neck cancer-specific quality of life: Instrument validation Arch Otolaryngol Head Neck Surg 123 1997 1125 1132
14. S.J. Hassan, and E.A. Weymuller Assessment of quality of life in head and neck cancer patients Head Neck 15 1993 485 496
15. J.E. Ware Jr., and B. Gandek Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project J Clin Epidemiol 51 1998 903 912
16. D. Osoba, G. Rodrigues, and J. Myles Interpreting the significance of changes in health-related quality-of-life scores J Clin Oncol 16 1998 139 144
17. Y.K. Tu, V. Clerehugh, and M.S. Gilthorpe Collinearity in linear regression is a serious problem in oral health research Eur J Oral Sci 112 2004 389 397
18. M. Machtay, J. Moughan, and A. Trotti Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis J Clin Oncol 26 2008 3582 3589
19. J.J. Wang, T.A. Goldsmith, and A.S. Holman Pharyngoesophageal stricture after treatment for head and neck cancer Head Neck 34 2012 967 973
20. M.K. Bhayani, K.A. Hutcheson, and D.A. Barringer Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: Factors affecting placement and dependence Head Neck 35 2013 1634 1640
21. J. Setton, N. Caria, and J. Romanyshyn Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: An update of the Memorial Sloan-Kettering Cancer Center experience Int J Radiat Oncol Biol Phys 82 2012 291 298
22. K.A. Hutcheson, J.S. Lewin, and F.C. Holsinger Long-term functional and survival outcomes after induction chemotherapy and risk-based definitive therapy for locally advanced squamous cell carcinoma of the head and neck Head Neck 36 2014 474 480
23. A.H. Ackerstaff, C.R. Rasch, and A.J. Balm Five-year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra-arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer Head Neck 34 2012 974 980
24. A.K. Chaturvedi, E.A. Engels, and R.M. Pfeiffer Human papillomavirus and rising oropharyngeal cancer incidence in the United States J Clin Oncol 29 2011 4294 4301
25. K.K. Ang, J. Harris, and R. Wheeler Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 2010 24 35
26. H. Quon, and A.A. Forastiere Controversies in treatment deintensification of human papillomavirus-associated oropharyngeal carcinomas: Should we, how should we, and for whom? J Clin Oncol 31 2013 520 522
27. A. Eisbruch, H.M. Kim, and F.Y. Feng Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: Swallowing organs late complication probabilities and dosimetric correlates Int J Radiat Oncol Biol Phys 81 2011 e93 e99
28. G. Vlacich, D.E. Spratt, and R. Diaz Dose to the inferior pharyngeal constrictor predicts prolonged gastrostomy tube dependence with concurrent intensity-modulated radiation therapy and chemotherapy for locally advanced head and neck cancer Radiother Oncol 110 2014 435 440
29. H.R. Mortensen, K. Jensen, and K. Aksglaede Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters Radiother Oncol 107 2013 288 294
30. M.E. Christianen, C. Schilstra, and I. Beetz Predictive modelling for swallowing dysfunction after primary (chemo)radiation: Results of a prospective observational study Radiother Oncol 105 2012 107 114
31. S.A. Bhide, S. Gulliford, and R. Kazi Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer Radiother Oncol 93 2009 539 544
32. A. Bottomley, G. Tridello, and C. Coens An international phase 3 trial in head and neck cancer: Quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology Group Cancer 120 2014 390 398
33. B. Movsas, D. Hunt, and D. Watkins-Bruner Can electronic web-based technology improve quality of life data collection? Analysis of Radiation Therapy Oncology Group 0828 Pract Radiat Oncol 4 2014 187 191
34. B. O'Sullivan, S.H. Huang, and L.L. Siu Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis J Clin Oncol 31 2013 543 550
35. J.M. Vainshtein, M. Schipper, and J. DeYoung Impact of xerostomia on patients' perception of dysphagia after chemo-IMRT for oropharyngeal cancer (OPC) Int J Radiat Oncol Biol Phys 90 2014 S100
36. M. Little, M. Schipper, and F.Y. Feng Reducing xerostomia after chemo-IMRT for head-and-neck cancer: Beyond sparing the parotid glands Int J Radiat Oncol Biol Phys 83 2012 1007 1014